Co-Diagnostics Ownership | Who Owns Co-Diagnostics?

Overview Forecast RevenueFinancials Chart Transcripts

Co-Diagnostics Ownership Summary

Co-Diagnostics is owned by 16.97% institutional investors, 5.09% insiders, and 77.94% retail investors. Vanguard group is the largest institutional shareholder, holding 5.15% of CODX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.01% of its assets in Co-Diagnostics shares.

CODX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Co-Diagnostics	16.97%	5.09%	77.94%
Sector	Healthcare Stocks	42.50%	10.81%	46.69%
Industry	Medical Device Stocks	37.66%	10.02%	52.32%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.71M	5.15%	$586.85K
Private advisory group	1.18M	3.57%	$406.48K
Renaissance	867.52K	2.62%	$298.43K
Blackrock	502.02K	1.68%	$627.53K
Blackrock funding, inc. /de	427.44K	1.29%	$147.04K
Geode capital management	319.99K	0.97%	$110.11K
Susquehanna group, llp	259.13K	0.85%	$194.34K
Hrt financial lp	149.29K	0.45%	$51.00K
Bank of new york mellon	137.07K	0.41%	$47.15K
Kestra advisory services	134.69K	0.41%	$46.34K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Private advisory group	1.18M	0.03%	$406.48K
Ground swell capital	11.52K	0.01%	$3.96K
Virtu financial	126.52K	0.00%	$44.00K
Smi advisory services	28.00K	0.00%	$10.75K
Regal investment advisors	16.00K	0.00%	$5.50K
Renaissance	867.52K	0.00%	$298.43K
Hrt financial lp	149.29K	0.00%	$51.00K
Kestra advisory services	134.69K	0.00%	$46.34K
Triton wealth management, p	-	-	-
Engineers gate manager lp	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	867.52K	0.00%	306.50K
Hrt financial lp	149.29K	0.00%	135.99K
Ubs group	118.24K	-	116.99K
Virtu financial	126.52K	0.00%	100.90K
Susquehanna group, llp	259.13K	-	71.56K

Top Sellers

Holder	Shares	% Assets	Change
Bridgeway capital management	-	-	-272.90K
Jane street group	62.25K	-	-104.00K
Squarepoint ops	-	-	-65.80K
Koss-olinger consulting	-	-	-58.10K
Thompson davis	-	-	-57.20K

New Positions

Holder	Shares	% Assets	Change	Value
Goldman sachs group	15.99K	-	15.99K	$11.99K
Ground swell capital	11.52K	0.01%	11.52K	$3.96K

Sold Out

Holder	Change
Qube research	-13.00
Northwestern mutual wealth management	-100.00
Financial network wealth advisors	-100.00
National bank of canada /fi/	-200.00
Fmr	-218.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	35	-2.78%	5,618,778	9.06%	16	6.57%	11	-15.38%	9	-
Jun 30, 2025	36	-7.69%	5,162,038	-11.65%	16	4.85%	13	-18.75%	9	12.50%
Mar 31, 2025	1	-97.67%	40,149	-99.30%	-	0.04%	1	-93.33%	-	-100.00%
Dec 31, 2024	43	7.50%	5,722,186	29.65%	18	8.96%	15	66.67%	9	-18.18%
Sep 30, 2024	39	-15.22%	4,402,641	-5.17%	14	5.97%	9	-57.14%	10	42.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.28M	4.01%	-
Vanguard Total Stock Mkt Idx Inv	1.25M	3.45%	-27.29K
Vanguard Institutional Extnd Mkt Idx Tr	305.55K	0.84%	-139.23K
Bridgeway Ultra-Small Company	272.90K	0.81%	-
Fidelity Extended Market Index	158.61K	0.41%	-1.12K
BlackRock Extended Equity Market K	72.43K	0.23%	-31.00
Extended Equity Market Fund K	70.27K	0.21%	-1.40K
iShares Micro-Cap ETF	62.55K	0.19%	-
Fidelity Total Market Index	53.05K	0.14%	-
Spartan Total Market Index Pool E	43.70K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 20, 2023	Brown Brian Lee	Chief Financial Officer	Buy	$5.70K
Sep 08, 2021	Durenard Eugene	-	Sell	$20.91K
May 19, 2021	BENSON REED L	General Counsel	Sell	$830.39K
May 19, 2021	BENSON REED L	General Counsel	Sell	$8.53
May 19, 2021	BENSON REED L	General Counsel	Sell	$93.23K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	-
2024 Q2	-	-

CODX Ownership FAQ

Who Owns Co-Diagnostics?

Co-Diagnostics shareholders are primarily institutional investors at 16.97%, followed by 5.09% insiders and 77.94% retail investors. The average institutional ownership in Co-Diagnostics's industry, Medical Device Stocks, is 37.66%, which Co-Diagnostics falls below.

Who owns the most shares of Co-Diagnostics?

Co-Diagnostics’s largest shareholders are Vanguard group (1.71M shares, 5.15%), Private advisory group (1.18M shares, 3.57%), and Renaissance (867.52K shares, 2.62%). Together, they hold 11.34% of Co-Diagnostics’s total shares outstanding.

Does Blackrock own Co-Diagnostics?

Yes, BlackRock owns 1.68% of Co-Diagnostics, totaling 502.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 627.53K$. In the last quarter, BlackRock increased its holdings by 1.98K shares, a 0.40% change.

Who is Co-Diagnostics’s biggest shareholder by percentage of total assets invested?

Private advisory group is Co-Diagnostics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 1.18M Co-Diagnostics shares, valued at 406.48K$.

Who is the top mutual fund holder of Co-Diagnostics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Co-Diagnostics shares, with 4.01% of its total shares outstanding invested in 1.28M Co-Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools